Pancreatic	B:C0030274
Cystic	O
Lesions	I:C1511606
:	O
Diagnostic	O
,	O
Management	O
and	O
Indications	O
for	O
Operation	O
.	O

Pancreatic	O
Cystic	B:C1511606
Lesions	I:C1511606
:	O
Diagnostic	O
,	O
Management	O
and	O
Indications	O
for	O
Operation	O
.	O

Pancreatic	O
Cystic	O
Lesions	I:C1511606
:	O
Diagnostic	B:C0011900
,	O
Management	O
and	O
Indications	O
for	O
Operation	O
.	O

Pancreatic	O
Cystic	O
Lesions	I:C1511606
:	O
Diagnostic	O
,	O
Management	B:C0376636
and	O
Indications	O
for	O
Operation	O
.	O

Pancreatic	O
Cystic	O
Lesions	I:C1511606
:	O
Diagnostic	O
,	O
Management	O
and	O
Indications	O
for	O
Operation	B:C0543467
.	O

We	O
notice	O
an	O
increasing	O
frequency	O
in	O
the	O
detection	B:C1511790
and	O
evaluation	O
of	O
pancreatic	O
cystic	O
lesions	I:C1511606
(	O
pancreatic	O
cystic	I:C1511606
lesions	I:C1511606
)	O
over	O
the	O
last	O
three	O
decades	O
.	O

We	O
notice	O
an	O
increasing	O
frequency	O
in	O
the	O
detection	O
and	O
evaluation	B:C0220825
of	O
pancreatic	O
cystic	O
lesions	I:C1511606
(	O
pancreatic	O
cystic	I:C1511606
lesions	I:C1511606
)	O
over	O
the	O
last	O
three	O
decades	O
.	O

We	O
notice	O
an	O
increasing	O
frequency	O
in	O
the	O
detection	O
and	O
evaluation	O
of	O
pancreatic	B:C0030274
cystic	O
lesions	I:C1511606
(	O
pancreatic	O
cystic	I:C1511606
lesions	I:C1511606
)	O
over	O
the	O
last	O
three	O
decades	O
.	O

We	O
notice	O
an	O
increasing	O
frequency	O
in	O
the	O
detection	O
and	O
evaluation	O
of	O
pancreatic	O
cystic	B:C1511606
lesions	I:C1511606
(	O
pancreatic	O
cystic	I:C1511606
lesions	I:C1511606
)	O
over	O
the	O
last	O
three	O
decades	O
.	O

We	O
notice	O
an	O
increasing	O
frequency	O
in	O
the	O
detection	O
and	O
evaluation	O
of	O
pancreatic	O
cystic	O
lesions	I:C1511606
(	O
pancreatic	B:C1511606
cystic	I:C1511606
lesions	I:C1511606
)	O
over	O
the	O
last	O
three	O
decades	O
.	O

They	O
show	O
awide	O
spectrum	O
of	O
imaging	B:C0011923
and	O
clinical	O
features	O
.	O

The	O
diagnosis	B:C0011900
and	O
discrimination	O
of	O
these	O
lesions	O
are	O
very	O
important	O
because	O
of	O
the	O
risk	O
for	O
concurrent	O
or	O
later	O
development	O
of	O
malignancy	O
.	O

The	O
diagnosis	O
and	O
discrimination	O
of	O
these	O
lesions	B:C1511606
are	O
very	O
important	O
because	O
of	O
the	O
risk	O
for	O
concurrent	O
or	O
later	O
development	O
of	O
malignancy	O
.	O

The	O
diagnosis	O
and	O
discrimination	O
of	O
these	O
lesions	O
are	O
very	O
important	O
because	O
of	O
the	O
risk	O
for	O
concurrent	O
or	O
later	O
development	O
of	O
malignancy	B:C4282132
.	O

The	O
main	O
reason	O
is	O
the	O
increased	O
awareness	B:C0004448
of	O
these	O
lesions	O
and	O
the	O
extensive	O
use	O
of	O
cross-sectional	O
imaging	O
,	O
an	O
always	O
improving	O
technique	O
(	O
1	O
)	O
.	O

The	O
main	O
reason	O
is	O
the	O
increased	O
awareness	O
of	O
these	O
lesions	B:C1511606
and	O
the	O
extensive	O
use	O
of	O
cross-sectional	O
imaging	O
,	O
an	O
always	O
improving	O
technique	O
(	O
1	O
)	O
.	O

Commonly	O
,	O
pancreatic	B:C1511606
cystic	I:C1511606
lesions	I:C1511606
are	O
diagnosed	O
incidentally	O
during	O
investigation	O
for	O
often	O
unrelated	O
and	O
nonspecific	O
abdominal	O
complaints	O
using	O
state	O
-	O
of	O
-	O
the	O
art	O
abdominal	O
imaging	O
(	O
CT	O
,	O
MRT	O
)	O
.	O

Commonly	O
,	O
pancreatic	O
cystic	I:C1511606
lesions	I:C1511606
are	O
diagnosed	B:C0011900
incidentally	O
during	O
investigation	O
for	O
often	O
unrelated	O
and	O
nonspecific	O
abdominal	O
complaints	O
using	O
state	O
-	O
of	O
-	O
the	O
art	O
abdominal	O
imaging	O
(	O
CT	O
,	O
MRT	O
)	O
.	O

Commonly	O
,	O
pancreatic	O
cystic	I:C1511606
lesions	I:C1511606
are	O
diagnosed	O
incidentally	O
during	O
investigation	B:C0220825
for	O
often	O
unrelated	O
and	O
nonspecific	O
abdominal	O
complaints	O
using	O
state	O
-	O
of	O
-	O
the	O
art	O
abdominal	O
imaging	O
(	O
CT	O
,	O
MRT	O
)	O
.	O

Commonly	O
,	O
pancreatic	O
cystic	I:C1511606
lesions	I:C1511606
are	O
diagnosed	O
incidentally	O
during	O
investigation	O
for	O
often	O
unrelated	B:C0445356
and	O
nonspecific	O
abdominal	O
complaints	O
using	O
state	O
-	O
of	O
-	O
the	O
art	O
abdominal	O
imaging	O
(	O
CT	O
,	O
MRT	O
)	O
.	O

Commonly	O
,	O
pancreatic	O
cystic	I:C1511606
lesions	I:C1511606
are	O
diagnosed	O
incidentally	O
during	O
investigation	O
for	O
often	O
unrelated	O
and	O
nonspecific	O
abdominal	B:C0000726
complaints	O
using	O
state	O
-	O
of	O
-	O
the	O
art	O
abdominal	O
imaging	O
(	O
CT	O
,	O
MRT	O
)	O
.	O

Commonly	O
,	O
pancreatic	O
cystic	I:C1511606
lesions	I:C1511606
are	O
diagnosed	O
incidentally	O
during	O
investigation	O
for	O
often	O
unrelated	O
and	O
nonspecific	O
abdominal	O
complaints	O
using	O
state	O
-	O
of	O
-	O
the	O
art	O
abdominal	B:C0000726
imaging	O
(	O
CT	O
,	O
MRT	O
)	O
.	O

Commonly	O
,	O
pancreatic	O
cystic	I:C1511606
lesions	I:C1511606
are	O
diagnosed	O
incidentally	O
during	O
investigation	O
for	O
often	O
unrelated	O
and	O
nonspecific	O
abdominal	O
complaints	O
using	O
state	O
-	O
of	O
-	O
the	O
art	O
abdominal	O
imaging	B:C0011923
(	O
CT	O
,	O
MRT	O
)	O
.	O

Commonly	O
,	O
pancreatic	O
cystic	I:C1511606
lesions	I:C1511606
are	O
diagnosed	O
incidentally	O
during	O
investigation	O
for	O
often	O
unrelated	O
and	O
nonspecific	O
abdominal	O
complaints	O
using	O
state	O
-	O
of	O
-	O
the	O
art	O
abdominal	O
imaging	O
(	O
CT	B:C0040405
,	O
MRT	O
)	O
.	O

Commonly	O
,	O
pancreatic	O
cystic	I:C1511606
lesions	I:C1511606
are	O
diagnosed	O
incidentally	O
during	O
investigation	O
for	O
often	O
unrelated	O
and	O
nonspecific	O
abdominal	O
complaints	O
using	O
state	O
-	O
of	O
-	O
the	O
art	O
abdominal	O
imaging	O
(	O
CT	O
,	O
MRT	B:C0024485
)	O
.	O

The	O
term	O
PCN	B:C1333190
denotes	O
a	O
histologically	O
heterogeneous	O
collection	O
of	O
neoplasms	O
showing	O
a	O
wide	O
spectrum	O
of	O
diagnoses	O
,	O
ranging	O
from	O
completely	O
benign	O
to	O
potentially	O
malignant	O
,	O
to	O
carcinoma	O
in	O
situ	I:C0444498
,	O
to	O
frankly	O
invasive	O
and	O
malignant	O
(	O
2,3	O
)	O
.	O

The	O
term	O
PCN	O
denotes	O
a	O
histologically	O
heterogeneous	O
collection	O
of	O
neoplasms	B:C0027651
showing	O
a	O
wide	O
spectrum	O
of	O
diagnoses	O
,	O
ranging	O
from	O
completely	O
benign	O
to	O
potentially	O
malignant	O
,	O
to	O
carcinoma	O
in	O
situ	I:C0444498
,	O
to	O
frankly	O
invasive	O
and	O
malignant	O
(	O
2,3	O
)	O
.	O

The	O
term	O
PCN	O
denotes	O
a	O
histologically	O
heterogeneous	O
collection	O
of	O
neoplasms	O
showing	O
a	O
wide	O
spectrum	O
of	O
diagnoses	B:C0011900
,	O
ranging	O
from	O
completely	O
benign	O
to	O
potentially	O
malignant	O
,	O
to	O
carcinoma	O
in	O
situ	I:C0444498
,	O
to	O
frankly	O
invasive	O
and	O
malignant	O
(	O
2,3	O
)	O
.	O

The	O
term	O
PCN	O
denotes	O
a	O
histologically	O
heterogeneous	O
collection	O
of	O
neoplasms	O
showing	O
a	O
wide	O
spectrum	O
of	O
diagnoses	O
,	O
ranging	O
from	O
completely	O
benign	O
to	O
potentially	O
malignant	O
,	O
to	O
carcinoma	B:C0007097
in	O
situ	I:C0444498
,	O
to	O
frankly	O
invasive	O
and	O
malignant	O
(	O
2,3	O
)	O
.	O

The	O
term	O
PCN	O
denotes	O
a	O
histologically	O
heterogeneous	O
collection	O
of	O
neoplasms	O
showing	O
a	O
wide	O
spectrum	O
of	O
diagnoses	O
,	O
ranging	O
from	O
completely	O
benign	O
to	O
potentially	O
malignant	O
,	O
to	O
carcinoma	O
in	B:C0444498
situ	I:C0444498
,	O
to	O
frankly	O
invasive	O
and	O
malignant	O
(	O
2,3	O
)	O
.	O

In	O
1978	O
,	O
Compagno	O
and	O
Oertel	O
were	O
the	O
first	O
to	O
recognize	O
the	O
crucial	O
distinction	O
between	O
the	O
serous	B:C0476127
and	I:C0476127
the	I:C0476127
mucinous	I:C0476127
cystic	I:C0476127
neoplasms	I:C0476127
of	O
the	O
pancreas	O
by	O
explaining	O
the	O
importance	O
of	O
identifying	O
the	O
mucinous	O
neoplasms	I:C1334811
because	O
of	O
their	O
overt	O
or	O
latent	O
malignant	O
potential	O
(	O
4,5	O
)	O
.	O

In	O
1978	O
,	O
Compagno	O
and	O
Oertel	O
were	O
the	O
first	O
to	O
recognize	O
the	O
crucial	O
distinction	O
between	O
the	O
serous	O
and	I:C0476127
the	I:C0476127
mucinous	I:C0476127
cystic	I:C0476127
neoplasms	I:C0476127
of	O
the	O
pancreas	B:C0030274
by	O
explaining	O
the	O
importance	O
of	O
identifying	O
the	O
mucinous	O
neoplasms	I:C1334811
because	O
of	O
their	O
overt	O
or	O
latent	O
malignant	O
potential	O
(	O
4,5	O
)	O
.	O

In	O
1978	O
,	O
Compagno	O
and	O
Oertel	O
were	O
the	O
first	O
to	O
recognize	O
the	O
crucial	O
distinction	O
between	O
the	O
serous	O
and	I:C0476127
the	I:C0476127
mucinous	I:C0476127
cystic	I:C0476127
neoplasms	I:C0476127
of	O
the	O
pancreas	O
by	O
explaining	O
the	O
importance	O
of	O
identifying	B:C0020792
the	O
mucinous	O
neoplasms	I:C1334811
because	O
of	O
their	O
overt	O
or	O
latent	O
malignant	O
potential	O
(	O
4,5	O
)	O
.	O

In	O
1978	O
,	O
Compagno	O
and	O
Oertel	O
were	O
the	O
first	O
to	O
recognize	O
the	O
crucial	O
distinction	O
between	O
the	O
serous	O
and	I:C0476127
the	I:C0476127
mucinous	I:C0476127
cystic	I:C0476127
neoplasms	I:C0476127
of	O
the	O
pancreas	O
by	O
explaining	O
the	O
importance	O
of	O
identifying	O
the	O
mucinous	B:C1334811
neoplasms	I:C1334811
because	O
of	O
their	O
overt	O
or	O
latent	O
malignant	O
potential	O
(	O
4,5	O
)	O
.	O

Since	O
then	O
,	O
the	O
interest	O
in	O
pancreatic	B:C1511606
cystic	I:C1511606
lesions	I:C1511606
increased	O
markedly	O
,	O
especially	O
so	O
with	O
the	O
recognition	O
of	O
the	O
importance	O
and	O
prevalence	O
of	O
intraductal	O
papillary	I:C3160815
mucinous	I:C3160815
neoplasms	I:C3160815
(	O
intraductal	O
papillary	I:C3160815
mucinous	I:C3160815
neoplasms	I:C3160815
)	O
.	O

Since	O
then	O
,	O
the	O
interest	O
in	O
pancreatic	O
cystic	I:C1511606
lesions	I:C1511606
increased	O
markedly	O
,	O
especially	O
so	O
with	O
the	O
recognition	O
of	O
the	O
importance	O
and	O
prevalence	O
of	O
intraductal	B:C3160815
papillary	I:C3160815
mucinous	I:C3160815
neoplasms	I:C3160815
(	O
intraductal	O
papillary	I:C3160815
mucinous	I:C3160815
neoplasms	I:C3160815
)	O
.	O

Since	O
then	O
,	O
the	O
interest	O
in	O
pancreatic	O
cystic	I:C1511606
lesions	I:C1511606
increased	O
markedly	O
,	O
especially	O
so	O
with	O
the	O
recognition	O
of	O
the	O
importance	O
and	O
prevalence	O
of	O
intraductal	O
papillary	I:C3160815
mucinous	I:C3160815
neoplasms	I:C3160815
(	O
intraductal	B:C3160815
papillary	I:C3160815
mucinous	I:C3160815
neoplasms	I:C3160815
)	O
.	O

Nowadays	O
,	O
pancreatic	B:C1511606
cystic	I:C1511606
lesions	I:C1511606
represent	O
a	O
common	O
and	O
often	O
difficult	O
challenge	O
in	O
clinical	O
practice	O
,	O
because	O
of	O
the	O
increase	O
in	O
their	O
detection	O
in	O
asymptomatic	O
patients	O
and	O
our	O
still	O
immature	O
understanding	O
of	O
some	O
aspects	O
of	O
their	O
biologic	O
behavior	O
.	O

Nowadays	O
,	O
pancreatic	O
cystic	I:C1511606
lesions	I:C1511606
represent	O
a	O
common	O
and	O
often	O
difficult	O
challenge	O
in	O
clinical	O
practice	O
,	O
because	O
of	O
the	O
increase	O
in	O
their	O
detection	B:C1511790
in	O
asymptomatic	O
patients	O
and	O
our	O
still	O
immature	O
understanding	O
of	O
some	O
aspects	O
of	O
their	O
biologic	O
behavior	O
.	O

Nowadays	O
,	O
pancreatic	O
cystic	I:C1511606
lesions	I:C1511606
represent	O
a	O
common	O
and	O
often	O
difficult	O
challenge	O
in	O
clinical	O
practice	O
,	O
because	O
of	O
the	O
increase	O
in	O
their	O
detection	O
in	O
asymptomatic	B:C0231221
patients	O
and	O
our	O
still	O
immature	O
understanding	O
of	O
some	O
aspects	O
of	O
their	O
biologic	O
behavior	O
.	O

Nowadays	O
,	O
pancreatic	O
cystic	I:C1511606
lesions	I:C1511606
represent	O
a	O
common	O
and	O
often	O
difficult	O
challenge	O
in	O
clinical	O
practice	O
,	O
because	O
of	O
the	O
increase	O
in	O
their	O
detection	O
in	O
asymptomatic	O
patients	O
and	O
our	O
still	O
immature	O
understanding	B:C0162340
of	O
some	O
aspects	O
of	O
their	O
biologic	O
behavior	O
.	O

Their	O
important	O
differences	O
regarding	O
their	O
outcome	O
and	O
the	O
fact	O
of	O
being	O
increasingly	O
often	O
identified	O
has	O
put	O
a	O
special	O
focus	O
on	O
these	O
neoplasms	B:C0027651
by	O
surgeons	O
,	O
pathologists	O
,	O
gastroenterologists	O
,	O
radiologists	O
,	O
and	O
oncologists	O
alike	O
.	O

Their	O
important	O
differences	O
regarding	O
their	O
outcome	O
and	O
the	O
fact	O
of	O
being	O
increasingly	O
often	O
identified	O
has	O
put	O
a	O
special	O
focus	O
on	O
these	O
neoplasms	O
by	O
surgeons	B:C0582175
,	O
pathologists	O
,	O
gastroenterologists	O
,	O
radiologists	O
,	O
and	O
oncologists	O
alike	O
.	O

Their	O
important	O
differences	O
regarding	O
their	O
outcome	O
and	O
the	O
fact	O
of	O
being	O
increasingly	O
often	O
identified	O
has	O
put	O
a	O
special	O
focus	O
on	O
these	O
neoplasms	O
by	O
surgeons	O
,	O
pathologists	B:C0334866
,	O
gastroenterologists	O
,	O
radiologists	O
,	O
and	O
oncologists	O
alike	O
.	O

Their	O
important	O
differences	O
regarding	O
their	O
outcome	O
and	O
the	O
fact	O
of	O
being	O
increasingly	O
often	O
identified	O
has	O
put	O
a	O
special	O
focus	O
on	O
these	O
neoplasms	O
by	O
surgeons	O
,	O
pathologists	O
,	O
gastroenterologists	B:C0259901
,	O
radiologists	O
,	O
and	O
oncologists	O
alike	O
.	O

Their	O
important	O
differences	O
regarding	O
their	O
outcome	O
and	O
the	O
fact	O
of	O
being	O
increasingly	O
often	O
identified	O
has	O
put	O
a	O
special	O
focus	O
on	O
these	O
neoplasms	O
by	O
surgeons	O
,	O
pathologists	O
,	O
gastroenterologists	O
,	O
radiologists	B:C0260194
,	O
and	O
oncologists	O
alike	O
.	O

Their	O
important	O
differences	O
regarding	O
their	O
outcome	O
and	O
the	O
fact	O
of	O
being	O
increasingly	O
often	O
identified	O
has	O
put	O
a	O
special	O
focus	O
on	O
these	O
neoplasms	O
by	O
surgeons	O
,	O
pathologists	O
,	O
gastroenterologists	O
,	O
radiologists	O
,	O
and	O
oncologists	B:C0259990
alike	O
.	O

Management	B:C0376636
of	O
patients	O
with	O
PCNs	O
can	O
be	O
challenging	O
and	O
varies	O
considerably	O
among	O
the	O
various	O
subtypes	O
of	O
PCNs	O
.	O

Management	O
of	O
patients	O
with	O
PCNs	B:C1333190
can	O
be	O
challenging	O
and	O
varies	O
considerably	O
among	O
the	O
various	O
subtypes	O
of	O
PCNs	O
.	O

Management	O
of	O
patients	O
with	O
PCNs	O
can	O
be	O
challenging	B:C0805586
and	O
varies	O
considerably	O
among	O
the	O
various	O
subtypes	O
of	O
PCNs	O
.	O

Management	O
of	O
patients	O
with	O
PCNs	O
can	O
be	O
challenging	O
and	O
varies	O
considerably	O
among	O
the	O
various	O
subtypes	B:C0449560
of	O
PCNs	O
.	O

Management	O
of	O
patients	O
with	O
PCNs	O
can	O
be	O
challenging	O
and	O
varies	O
considerably	O
among	O
the	O
various	O
subtypes	O
of	O
PCNs	B:C1333190
.	O

Their	O
treatment	B:C0087111
ranges	O
from	O
resection	O
of	O
malignant	O
lesions	O
,	O
to	O
resection	O
and	O
/	O
or	O
surveillance	O
in	O
the	O
case	O
of	O
premalignant	O
lesions	I:C0850639
,	O
to	O
simple	O
observation	O
in	O
the	O
case	O
of	O
benign	O
or	O
indolent	O
lesions	O
.	O

Their	O
treatment	O
ranges	O
from	O
resection	B:C0728940
of	O
malignant	O
lesions	O
,	O
to	O
resection	O
and	O
/	O
or	O
surveillance	O
in	O
the	O
case	O
of	O
premalignant	O
lesions	I:C0850639
,	O
to	O
simple	O
observation	O
in	O
the	O
case	O
of	O
benign	O
or	O
indolent	O
lesions	O
.	O

Their	O
treatment	O
ranges	O
from	O
resection	O
of	O
malignant	O
lesions	B:C1511606
,	O
to	O
resection	O
and	O
/	O
or	O
surveillance	O
in	O
the	O
case	O
of	O
premalignant	O
lesions	I:C0850639
,	O
to	O
simple	O
observation	O
in	O
the	O
case	O
of	O
benign	O
or	O
indolent	O
lesions	O
.	O

Their	O
treatment	O
ranges	O
from	O
resection	O
of	O
malignant	O
lesions	O
,	O
to	O
resection	B:C0728940
and	O
/	O
or	O
surveillance	O
in	O
the	O
case	O
of	O
premalignant	O
lesions	I:C0850639
,	O
to	O
simple	O
observation	O
in	O
the	O
case	O
of	O
benign	O
or	O
indolent	O
lesions	O
.	O

Their	O
treatment	O
ranges	O
from	O
resection	O
of	O
malignant	O
lesions	O
,	O
to	O
resection	O
and	O
/	O
or	O
surveillance	B:C0733511
in	O
the	O
case	O
of	O
premalignant	O
lesions	I:C0850639
,	O
to	O
simple	O
observation	O
in	O
the	O
case	O
of	O
benign	O
or	O
indolent	O
lesions	O
.	O

Their	O
treatment	O
ranges	O
from	O
resection	O
of	O
malignant	O
lesions	O
,	O
to	O
resection	O
and	O
/	O
or	O
surveillance	O
in	O
the	O
case	O
of	O
premalignant	B:C0850639
lesions	I:C0850639
,	O
to	O
simple	O
observation	O
in	O
the	O
case	O
of	O
benign	O
or	O
indolent	O
lesions	O
.	O

Their	O
treatment	O
ranges	O
from	O
resection	O
of	O
malignant	O
lesions	O
,	O
to	O
resection	O
and	O
/	O
or	O
surveillance	O
in	O
the	O
case	O
of	O
premalignant	O
lesions	I:C0850639
,	O
to	O
simple	O
observation	B:C0302523
in	O
the	O
case	O
of	O
benign	O
or	O
indolent	O
lesions	O
.	O

Their	O
treatment	O
ranges	O
from	O
resection	O
of	O
malignant	O
lesions	O
,	O
to	O
resection	O
and	O
/	O
or	O
surveillance	O
in	O
the	O
case	O
of	O
premalignant	O
lesions	I:C0850639
,	O
to	O
simple	O
observation	O
in	O
the	O
case	O
of	O
benign	O
or	O
indolent	O
lesions	B:C1511606
.	O

Under	O
these	O
circumstances	O
,	O
the	O
accurate	O
classification	B:C0008902
of	O
PCNs	O
becomes	O
crucial	O
.	O

Under	O
these	O
circumstances	O
,	O
the	O
accurate	O
classification	O
of	O
PCNs	B:C1333190
becomes	O
crucial	O
.	O

Therapeutic	O
decision	O
making	O
and	O
classification	B:C0008902
rely	O
mainly	O
on	O
the	O
presenting	O
symptoms	O
and	O
radiologic	O
findings	I:C1290916
,	O
often	O
without	O
actual	O
histologic	O
tissue	O
.	O

Therapeutic	O
decision	O
making	O
and	O
classification	O
rely	O
mainly	O
on	O
the	O
presenting	O
symptoms	B:C1457887
and	O
radiologic	O
findings	I:C1290916
,	O
often	O
without	O
actual	O
histologic	O
tissue	O
.	O

Therapeutic	O
decision	O
making	O
and	O
classification	O
rely	O
mainly	O
on	O
the	O
presenting	O
symptoms	O
and	O
radiologic	B:C1290916
findings	I:C1290916
,	O
often	O
without	O
actual	O
histologic	O
tissue	O
.	O

Therapeutic	O
decision	O
making	O
and	O
classification	O
rely	O
mainly	O
on	O
the	O
presenting	O
symptoms	O
and	O
radiologic	O
findings	I:C1290916
,	O
often	O
without	O
actual	O
histologic	O
tissue	B:C0040300
.	O

It	O
is	O
of	O
extreme	O
importance	O
to	O
identify	O
suspicious	O
features	O
indicating	O
potential	O
or	O
certain	O
malignancy	B:C4282132
in	O
order	O
to	O
select	O
the	O
appropriate	O
treatment	O
.	O

It	O
is	O
of	O
extreme	O
importance	O
to	O
identify	O
suspicious	O
features	O
indicating	O
potential	O
or	O
certain	O
malignancy	O
in	O
order	O
to	O
select	O
the	O
appropriate	O
treatment	B:C0087111
.	O

The	O
risk	O
of	O
overtreatment	B:C4046039
(	O
unnecessary	O
pancreatectomy	O
)	O
should	O
he	O
balanced	O
carefully	O
with	O
the	O
risk	O
of	O
under	O
treatment	O
(	O
missing	O
the	O
opportunity	O
to	O
cure	O
a	O
potentially	O
curable	O
malignant	O
or	O
premalignant	O
disease	O
)	O
.	O

The	O
risk	O
of	O
overtreatment	O
(	O
unnecessary	O
pancreatectomy	B:C0030279
)	O
should	O
he	O
balanced	O
carefully	O
with	O
the	O
risk	O
of	O
under	O
treatment	O
(	O
missing	O
the	O
opportunity	O
to	O
cure	O
a	O
potentially	O
curable	O
malignant	O
or	O
premalignant	O
disease	O
)	O
.	O

The	O
risk	O
of	O
overtreatment	O
(	O
unnecessary	O
pancreatectomy	O
)	O
should	O
he	O
balanced	O
carefully	O
with	O
the	O
risk	O
of	O
under	O
treatment	B:C0087111
(	O
missing	O
the	O
opportunity	O
to	O
cure	O
a	O
potentially	O
curable	O
malignant	O
or	O
premalignant	O
disease	O
)	O
.	O

The	O
risk	O
of	O
overtreatment	O
(	O
unnecessary	O
pancreatectomy	O
)	O
should	O
he	O
balanced	O
carefully	O
with	O
the	O
risk	O
of	O
under	O
treatment	O
(	O
missing	O
the	O
opportunity	O
to	O
cure	O
a	O
potentially	O
curable	O
malignant	O
or	O
premalignant	O
disease	B:C0012634
)	O
.	O

